U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
  • Quoted phrase not found.
  • See the search details.
Lumasiran (Oxlumo): CADTH Reimbursement Recommendation: Indication: For the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients [Internet].

Lumasiran (Oxlumo): CADTH Reimbursement Recommendation: Indication: For the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.

Table of contents

1.

Lumasiran (Oxlumo): CADTH Reimbursement Recommendation: Indication: For the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients [Internet].

Supplemental Content

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...